Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
T2 Biosystems (TTOO)
:TTOO
Holding TTOO?
Track your performance easily
Earnings Data
Report Date
Feb 26, 2025TBA Not Confirmed
Period Ending
2024 (Q4)Consensus EPS Forecast
―Last Year’s EPS
-2.2Same Quarter Last Year
Based on 0 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Nov 01, 2018
|% Change Since: -50.00%
|Next Earnings Date:Aug 02, 2018
Earnings Call Sentiment|Neutral
T2 Biosystems demonstrated significant revenue growth and strategic partnerships, notably with Cardinal Health, which could drive future success. However, financial challenges such as a substantial net loss and NASDAQ compliance issues are concerning. The sentiment is balanced by the potential of new product launches and operational improvements.Company Guidance
During the third quarter 2024 earnings call for T2 Biosystems, CEO John Sperzel outlined significant progress toward the company's three corporate priorities: accelerating sales, enhancing operations, and advancing the product pipeline. The company reported a 34% increase in total revenue compared to the previous year, driven by a 173% growth in U.S. T2Bacteria Panel sales and a 78% increase in international T2Dx Instrument sales. T2 Biosystems also secured an exclusive distribution agreement with Cardinal Health, aiming to expand its reach to over 6,000 U.S. hospitals, and a co-marketing collaboration with Prxcision to enhance antibiotic stewardship. Additionally, the company converted approximately 80% of its debt into common stock and implemented cost-saving measures projected to save $1.4 million annually. On the product development front, T2 Biosystems is preparing to submit the T2Resistance Panel for FDA clearance in Q1 2025 and plans to initiate the commercialization of the T2Lyme Panel in time for the 2025 Lyme season.Significant Revenue Growth
T2 Biosystems reported third quarter revenue of $2.0 million, representing a 34% increase compared to the prior year period.
Expansion Through Cardinal Health Partnership
T2 Biosystems entered an exclusive commercial distribution agreement with Cardinal Health, aimed at accelerating revenue growth and expanding access to over 6,000 U.S. hospitals.
Strong International Sales
The company executed contracts for 11 T2Dx Instruments, including 10 internationally, leading to a 78% increase in international instrument sales compared to the third quarter of 2023.
Debt Reduction and Cost Savings
Approximately 80% of debt converted to common stock, reducing quarterly interest payments. Operational changes expected to save over $1.4 million annually.
Product Pipeline Developments
FDA breakthrough device designations for several products, with plans to submit the T2Resistance Panel for FDA clearance in early 2025.
---
TTOO Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
TTOO Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Nov 14, 2024 | $0.52 | $0.50 | -3.85% |
| Jul 29, 2024 | $4.74 | $4.89 | +3.16% |
| May 06, 2024 | $3.63 | $3.24 | -10.74% |
| Feb 15, 2024 | $6.39 | $5.45 | -14.71% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does T2 Biosystems (TTOO) report earnings?
T2 Biosystems (TTOO) is schdueled to report earning on Feb 26, 2025, TBA Not Confirmed.
What is T2 Biosystems (TTOO) earnings time?
T2 Biosystems (TTOO) earnings time is at Feb 26, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is TTOO EPS forecast?
Currently, no data Available
---